Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation.

Bürger C, Maschmeier M, Hüsing-Kabar A, Wilms C, Köhler M, Schmidt M, Schmidt HH, Kabar I.

Can J Gastroenterol Hepatol. 2019 Jan 8;2019:5796074. doi: 10.1155/2019/5796074. eCollection 2019.

2.

Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From Atp7b-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.

Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, Borchard S, Zibert A, Schmidt HH, Di Schiavi E, Puchkova LV, Franco B, Kroemer G, Zischka H, Polishchuk RS.

Gastroenterology. 2018 Nov 17. pii: S0016-5085(18)35280-6. doi: 10.1053/j.gastro.2018.11.032. [Epub ahead of print]

PMID:
30452922
3.

Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant Recipients.

Kabar I, Hüsing-Kabar A, Maschmeier M, Völler C, Dümke M, Schmidt HH, Heinzow H.

Ann Transplant. 2018 Sep 28;23:674-680. doi: 10.12659/AOT.910278.

4.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.

PMID:
30145929
5.

Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure.

Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I.

J Int Med Res. 2018 Sep;46(9):3979-3990. doi: 10.1177/0300060518785543. Epub 2018 Jul 12.

6.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T.

N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

7.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB.

N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.

8.

Novel score predicts risk for cytomegalovirus infection in ulcerative colitis.

Nowacki TM, Bettenworth D, Meister T, Heidemann J, Lenze F, Schmidt HH, Heinzow HS.

J Clin Virol. 2018 Aug;105:103-108. doi: 10.1016/j.jcv.2018.06.002. Epub 2018 Jun 9.

PMID:
29940421
9.

Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease.

Guttmann S, Bernick F, Naorniakowska M, Michgehl U, Groba SR, Socha P, Zibert A, Schmidt HH.

Front Pediatr. 2018 Apr 30;6:106. doi: 10.3389/fped.2018.00106. eCollection 2018.

10.

Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells.

Guttmann S, Chandhok G, Groba SR, Niemietz C, Sauer V, Gomes A, Ciarimboli G, Karst U, Zibert A, Schmidt HH.

Oncotarget. 2017 Dec 12;9(1):743-754. doi: 10.18632/oncotarget.23142. eCollection 2018 Jan 2.

11.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P; EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.

PMID:
29391267
12.

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.

Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, Stewart M, Fallet S, Amass L.

Muscle Nerve. 2018 May;57(5):829-837. doi: 10.1002/mus.26034. Epub 2018 Feb 1.

13.

Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure.

Groba SR, Guttmann S, Niemietz C, Bernick F, Sauer V, Hachmöller O, Karst U, Zischka H, Zibert A, Schmidt HH.

Metallomics. 2017 Sep 20;9(9):1279-1287. doi: 10.1039/c7mt00189d.

PMID:
28805879
14.

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med. 2017 Oct;45(10):1616-1624. doi: 10.1097/CCM.0000000000002562.

15.

Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Wilms C, Hüsing-Kabar A, Görlich D, Kabar I, Schmidt HH.

PLoS One. 2017 Apr 12;12(4):e0175529. doi: 10.1371/journal.pone.0175529. eCollection 2017.

16.

[Extracorporeal Liver Replacement Therapy: Already Standard Procedure].

Gerth HU, Pohlen M, Schmidt HH.

Dtsch Med Wochenschr. 2017 Mar;142(5):367-368. doi: 10.1055/s-0042-113860. Epub 2017 Mar 10. German. No abstract available.

PMID:
28282685
17.

Intragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis.

Todorov T, Balakrishnan P, Savov A, Socha P, Schmidt HH.

PLoS One. 2016 Dec 19;11(12):e0168372. doi: 10.1371/journal.pone.0168372. eCollection 2016.

18.

 Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation.

Pillukat MH, Schomacher T, Baier P, Gabriëls G, Pavenstädt H, Schmidt HH.

Ann Hepatol. 2016 Sep-Oct;15(5):775-87. doi: 10.5604/16652681.1212613.

19.

Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, Eberhagen C, Rieder T, Janik D, Neff F, Straub BK, Schirmacher P, DiSpirito AA, Bandow N, Baral BS, Flatley A, Kremmer E, Denk G, Reiter FP, Hohenester S, Eckardt-Schupp F, Dencher NA, Adamski J, Sauer V, Niemietz C, Schmidt HH, Merle U, Gotthardt DN, Kroemer G, Weiss KH, Zischka H.

J Clin Invest. 2016 Jul 1;126(7):2721-35. doi: 10.1172/JCI85226. Epub 2016 Jun 20.

20.

Lipids in liver transplant recipients.

Hüsing A, Kabar I, Schmidt HH.

World J Gastroenterol. 2016 Mar 28;22(12):3315-24. doi: 10.3748/wjg.v22.i12.3315. Review.

Supplemental Content

Loading ...
Support Center